# Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial

> **NCT02175225** · PHASE2 · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 294 (actual)

## Conditions studied

- Intracerebral Hemorrhage

## Interventions

- **DRUG:** Deferoxamine Mesylate
- **DRUG:** Placebo (for Deferoxamine Mesylate)

## Key facts

- **NCT ID:** NCT02175225
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2018-02-10
- **Final completion:** 2018-05-30
- **Target enrollment:** 294 (ACTUAL)
- **Last updated:** 2019-05-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02175225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02175225, "Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02175225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*